Company Overview

At UBI Pharma Inc., we boast several patented technology platforms, including the Specialty Injectable Development Platform (peptide & lyophilized formulation), Multicomponent Tablet Formulation Technology Platform, Long-Acting Small Molecule Drug Technology Platform, and Long-Acting Protein Drug Development Technology. In 2018, we introduced the International Contract Development and Manufacturing (CDMO) one-stop service business model, complementing our original Contract Manufacturing service (CMO). Our exceptional team spans the spectrum of protein and specialty injectable drug development, mass production technology, clinical expertise, regulatory affairs, and pharmaceutical manufacturing management. Our core mission is to deliver top-notch services, expediting our clients' products from concept to the market. Our pharmaceutical experts and stringent quality management system draw from our heritage with internationally renowned pharmaceutical giant GlaxoSmithKline (GSK), giving us extensive experience in PIC/S GMP. Notably, we have manufactured Japanese encephalitis and tetanus vaccines for the Taiwan Centers for Disease Control (CDC) and continue to be a trusted manufacturing partner for controlled drugs commissioned by the Taiwan Food and Drug Administration (TFDA). Our facility has undergone rigorous inspections by multinational regulatory agencies, including the US FDA, Japan PMDA, and Ukraine SMDC. Our products have proudly reached the United States, Japan, and other advanced nations, showcasing UBI Pharma Inc.'s exceptional manufacturing capacity, equipment scale, and personnel excellence. With a firm foundation, we remain unwavering in our commitment to adhere to international PIC/S GMP guidelines for pharmaceuticals. Our current annual capacity for injectable vials stands at 11.2 million vials. As part of our dedication to meeting global demand, we embarked on a production line expansion in 2022, anticipating a four-fold increase in production capacity upon completion. Based in Taiwan, UBI Pharma Inc. steadfastly upholds its mission to provide high-quality business, technology, and manufacturing services to global customers. With a focus on Europe, America, Japan, and beyond, we are determined to disseminate our services and products worldwide, thereby making significant contributions to the dynamic fields of biotechnology and pharmaceuticals.